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In the present study we have investigated processing and maturation of the nonstructural small glycoprotein (sGP) of Ebola
virus. When sGP expressed from vaccinia virus vectors was analyzed by pulse-chase experiments using SDS–PAGE under
reducing conditions, the mature form and two different precursors have been identified. First, the endoplasmic reticulum form
sGPer, full-length sGP with oligomannosidic N-glycans, was detected, sGPer was then replaced by the Golgi-specific precursor
pre-sGP, full-length sGP containing complex N-glycans. This precursor was finally converted by proteolysis into mature sGP
and a smaller cleavage fragment, D-peptide. Studies employing site-directed mutagenesis revealed that sGP was cleaved at
a multibasic amino acid motif at positions 321 to 324 of the open reading frame. Cleavage was blocked by RVKR-chloromethyl
ketone. Uncleaved pre-sGP forms a disulfide-linked homodimer and is secreted into the culture medium in the presence of
the inhibitor as efficiently as proteolytically processed sGP. In vitro treatment of pre-sGP by purified recombinant furin
resulted in efficient cleavage, confirming the importance of this proprotein convertase for the processing and maturation of
sGP. D-peptide is also secreted into the culture medium and therefore represents a novel nonstructural expression product
of the GP gene of Ebola virus. Both cleavage fragments contain sialic acid, but only D-peptide is highly O-glycosylated. © 1999
Academic PressKey Words: Ebola virus; glycoprotein; proprotein convertase; proteolytic processing; O-glycosylation.
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Ebola virus (EBOV) and Marburg virus, the two species
ithin the family Filoviridae, are among the most patho-
enic human viruses causing fulminant hemorrhagic fe-
er in humans and nonhuman primates (Feldmann and
lenk, 1996). The negative-strand RNA genome of these
iruses encodes seven structural proteins. Genomic
NA, together with the viral structural proteins VP30,
P35, nucleoprotein NP, and polymerase protein L, form
he helical ribonucleoprotein complex. Three other pro-
eins [envelope glycoprotein (GP), VP40, and VP24] are
embrane associated (Feldmann and Kiley, 1999). In
eneral, filoviral genes are transcribed into monocis-
ronic subgenomic RNA species (mRNA) (Feldmann et
l., 1992; Sanchez et al., 1993). In contrast to all other
iloviral genes, including the GP gene of Marburg virus
Will et al., 1993), the organization and transcription of the
P gene of EBOV is unusual and involves transcriptional
NA editing (Volchkov et al., 1995; Sanchez et al., 1996).
P is synthesized as a large precursor, 676 amino acids
n length. GP is posttranslationally cleaved by furin into
he subunits GP1 (140 kDa) and GP2 (26 kDa) that are
1 Part of this work was presented at the XIth International Congress
f Virology, Sydney, Australia, August 9–13, 1999.
2 To whom correspondence should be addressed. Fax: 06421 286
e962. E-mail: volchkov@mailer.uni-marburg.de.
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164inked by a disulfide bond in the mature complex GP1,2
Volchkov et al., 1998a). The amino-terminal fragment
P1 is not only present in spikes, but is also shed after
elease of the disulfide linkage (Volchkov et al., 1998b). A
onstructural small glycoprotein (sGP) is synthesized
rom the unedited GP mRNA and extensively secreted
rom infected cells as a homodimer in antiparallel orien-
ation (Sanchez et al., 1998; Volchkova et al., 1998). sGP
hares its 295 amino-terminal amino acids with GP, but
iffers from GP in its 69 carboxy-terminal amino acids as
result of transcriptional editing (Volchkov et al., 1995;
anchez et al., 1996). It is conceivable that sGP, which is
ecreted in high amounts, might serve as a decoy, bind-
ng to protective antibodies and interfering with the spe-
ific immune response to transmembrane GP exposed
n viral or cellular surfaces. It has also been postulated
hat recombinant sGP could bind to neutrophils and may
nhibit their activation (Yang et al., 1998). Both proposed
unctions of sGP, inhibition of the inflammatory response
nd interference with the immune response, could be
mportant pathomechanisms in Ebola hemorrhagic fever.
In the present study, synthesis, transport, and process-
ng of sGP have been investigated. We have demon-
trated that EBOV sGP is proteolytically cleaved at a site
howing the recognition motif for subtilisin-like pro-
eases. Analysis of intracellular processing and transport
f EBOV sGP showed that it is first detected as an
ndoplasmic precursor (sGPer), which is converted into
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165PROTEOLYTIC PROCESSING OF EBOV sGPn endo H–resistant precursor (pre-sGP). Subsequently,
his precursor is cleaved into sGP and carboxy-terminal
-peptide, which are both secreted into the culture me-
ium. EBOV D-peptide is a glycopeptide, which is O-
lycosylated and sialylated.
RESULTS AND DISCUSSION
BOV sGP undergoes posttranslational proteolytic
leavage
In order to better understand the sequence of sGP
aturation steps, pulse-chase labeling experiments
ere performed. Cells infected with the recombinant
accinia virus vSCGP7 expressing sGP (Volchkov et al.,
995) were pulse-labeled for 20 min with [35S]cysteine,
hased for different time intervals prior to lysis, and
roteins from lysed cells and culture supernatants were
mmunoprecipitated using goat anti-EBOV immunoglobu-
ins. Analysis of sGP expression by SDS–PAGE under
educing conditions showed that immediately after
ulse-labeling sGP appeared in a 50-kDa form (sGPer)
Fig. 1) that has previously been identified as the endo
–sensitive endoplasmic reticulum precursor protein
Volchkov et al., 1995). Formation of disulfide-linked
imers in the ER is a limiting step during maturation and
ransport of sGP (Volchkova et al., 1998). As demon-
trated by analysis under nonreducing conditions, a sub-
tantial part of the pulse-labeled sGPer remained mono-
eric during the chase (Fig. 1A). sGPer often appeared as
double band, which was more clearly visible under
onreducing conditions. Since this doublet was con-
erted to a single band after digestion with endo H, it
ost likely reflects differences in glycosylation (Fig. 1C).
imers of sGPer first appeared after chase periods of
bout 20 min. After 40 min, part of dimeric sGPer was
onverted into the Golgi-specific precursor (pre-sGP).
hen analyzed under reducing conditions, pre-sGP ap-
eared as a diffuse band of approximately 60 kDa (Fig.
B) and showed resistance to endo H treatment (Fig. 1C).
fter digestion with endo H, the Golgi-precursor pre-sGP
ould be discriminated from the slightly faster migrating
GP band that overlapped with sGPer before endo H
reatment. sGP is the mature form of this glycoprotein
hat also was found in culture medium (Figs. 1A, 1B, and
C). The reduction in size observed after the final matu-
ation step suggested proteolytic cleavage of pre-sGP,
esulting in the removal of a short fragment which, how-
ver, was not detected with the anti-EBOV antibodies
sed in these experiments.
BOV sGP is cleaved at position R-V-R-R324
The deduced amino acid sequence of EBOV sGP con-
ains the multibasic motif R-V-R-R324, which is a potential
leavage site of furin or related subtilisin-like cellular
ndoproteases (Fig. 2). It should be noted that the furin tleavage sites of sGP and of the full-length envelope
lycoprotein GP are not identical, since they are en-
oded by different open reading frames (Volchkov et al.,
995). In order to verify that cleavage occurred at position
24, we changed the sequence R-V-R-R324 to R-V-R-S324 by
ite-directed mutagenesis using plasmid pGEM-mGP7
ith the genomic copy of the EBOV GP gene (Volchkov et
l., 1995). HeLa cells were infected with a recombinant
accinia virus expressing T7 RNA polymerase (vTF7-3)
nd then transfected with the plasmids coding for wild-
ype (wt) sGP and mutant R324S. Culture medium was
ollected 18 h posttransfection, separated on a 10%
DS–polyacrylamide gel under reducing conditions, and
nalyzed for the presence of sGP by immunoblotting
sing anti-EBOV antibodies. After substitution of R324,
re-sGP was no longer converted into sGP. The substi-
ution had no effect on secretion of this molecule into the
edium (Fig. 3A). These data demonstrate that sGP is
leaved at the sequence R-V-R-R324. The cleavage site of
GP shows the typical features of the consensus se-
uence recognized by furin or the related proprotein
onvertase PC5/6 (Nakayama, 1997; Steiner, 1998) and is
ighly conserved in all subtypes of EBOV (Fig. 2). In order
o obtain further information on the protease involved in
GP maturation, we carried out expression experiments
n the presence of the decanoylated peptidyl chloro-
ethyl ketone decRVKR-cmk, a potent inhibitor of the
ubtilisin-like endoprotease furin (Garten et al., 1994). As
hown in Figs. 1A and 1B, proteolytic processing was
bolished under these conditions, and noncleaved sGP
as secreted into the medium as efficiently as cleaved
GP.
Similar results were obtained when Vero-E6 cells in-
ected with EBOV strain Eckron were treated with the
nhibitor. Whereas no differences in virus production
ere noticed with or without decRVKR-cmk, the inhibitor
ffectively blocked cleavage of sGP (Fig. 3B). Since GP
lso undergoes proteolytic processing by a subtilisin-like
ellular endoprotease (Volchkov et al., 1998a; Volchkov,
999) treatment with inhibitor resulted in formation of
irions containing uncleaved GP.
-Peptide, the carboxy-terminal cleavage fragment, is
ecreted into the culture medium
The data described so far indicate that proteolytic
rocessing is the last step in sGP maturation. Anti-EBOV
ntibodies that were used for detection of either se-
reted sGP or of surface GP were not able to recognize
-peptide in immunoprecipitation or immunoblot exper-
ments. To identify the putative carboxy-terminal frag-
ent pre-sGP expressed in the presence of inhibitor was
igested with furin in vitro (Fig. 3C). Furin treatment
esulted in efficient cleavage of pre-sGP into sGP and a
econd cleavage fragment migrating as a diffuse bandhat has been designated D-peptide. Its molecular mass
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166 VOLCHKOVA, KLENK, AND VOLCHKOVf approximately 10–14 kDa is significantly higher than
he one predicted from the amino acid sequence (;4.7
Da), suggesting extensive posttranslational modifica-
ions present in D-peptide. Both cleavage fragments ap-
eared as individual bands when analyzed either under
FIG. 1. Synthesis, processing, and transport of EBOV sGP. HeLa cells
n methionine-cysteine-free medium for 1 h, and pulse-labeled for 20
abeling, and subsequent chase intervals, cells were either treated with
ere immunoprecipitated from cell lysates and culture medium usi
-mercaptoethanol (B), analyzed by 10% SDS–PAGE, and subsequently
recipitated samples were treated with endoglycosidase endo H and a
bove. The positions of sGP, endoplasmic precursor sGPer, and Go
eglycosylation with endo H.educing or nonreducing conditions, indicating the ab- tence of disulfide bonds between the molecules (data
ot shown). These results provide further support to the
oncept of sGP cleavage by furin or another endopro-
ease of similar substrate specificity.
In order to better visualize D-peptide and also to iden-
infected with vSCGP7. At 4 h postinfection cells were washed, starved
th 100 mCi/ml [35C]cysteine (Amersham, Germany). During starvation,
of decRVKR-cmk or incubated without inhibitor. sGP-specific proteins
i-EBOV immunoglobulins, treated with 2% SDS without (A) or with
ized by fluorography. (C) Endoglycosidase digestion of sGP. Immuno-
d on 10% polyacrylamide gel under reducing conditions as described
cursor pre-sGP are indicated. *sGPer, endoplasmic precursor afterwere
min wi
30 mM
ng ant
visual
nalyze
lgi-preify putative posttranslational modifications, a mutant
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167PROTEOLYTIC PROCESSING OF EBOV sGPontaining a 6xHis tag at the carboxy-terminal end has
een constructed. Immunoblotting and immunoprecipita-
ion assays using monoclonal anti-His antibodies al-
owed to detect the D-peptide cleaved in vivo (Figs. 4A,
B, and 4C). Both noncleaved sGP precursors (sGPer and
re-sGP) as well as the carboxy-terminal D-peptide were
ound in cells (Fig. 4A). In medium, besides minor
mounts of pre-sGP, secreted D-peptide was clearly de-
ected. Because of the carboxy-terminal location of the
xHis tag, mature sGP was not recognized by anti-His
ntibodies, but detected with anti-EBOV immunoglobu-
ins (Fig. 4B). Only noncleaved precursor has been de-
ected with anti-His antibodies with an sGP-His mutant
ontaining an Arg to Ser324 substitution was expressed in
eLa cells. This precursor molecule showed a higher
olecular mass than normally processed sGP when
nalyzed with anti-EBOV antibodies. In contrast to ma-
ure sGP that is secreted so efficiently that it usually
ould not be identified in cells using immunoblot analy-
is, D-peptide was retained in cells for longer time inter-
als. Whereas most of the sGP found in the culture
edium is cleaved, experiments with furin inhibitor and
he cleavage-site mutant demonstrated that cleavage is
FIG. 2. Schematic representation of EBOV sGP precursors and pro
-peptides of four subtypes of EBOV. Signal peptide and the carboxyter
utative sites for O-glycosylation are underlined. Cysteine residues invo
ites are indicated. The cleavage site at position 324 is indicated by aot required for secretion. Pulse-chase analysis of the Trocessing of sGP-His using anti-His antibodies re-
ealed that D-peptide was detected in the cell lysates
hortly after appearance of the Golgi-precursor and al-
ost disappeared at the 120-min time point due to se-
retion into the culture medium (Fig. 4C). It should be
oted that D-peptide migrated as a very diffuse band
hen analyzed by SDS–PAGE after immunoprecipitation,
ut showed a sharp band in the immunoblotting experi-
ents using anti-His antibodies.
-peptide is O-glycosylated and sialylated
EBOV D-peptide expressed in HeLa cells showed a
olecular mass that is larger than the one calculated
rom the amino acid content. Amino acid sequence anal-
sis showed that D-peptide of EBOV subtype Zaire does
ot contain sites for N-linked glycosylation, but that there
re five threonine and one serine residues that may
erve as attachment sites for O-glycans. Moreover, com-
arison of D-peptide sequences from all known EBOV
ubtypes revealed that all of them contain in the amino-
erminal part at least one dipeptide Pro-Thr, which is
nown as a favorable motif for O-glycosylation (Fig. 2).
ally processed products, and amino acid sequence alignment of the
-peptide are indicated by gray boxes. Threonine and serine residues,
sGP oligomerization are shown as S-S. Potential N-linked glycosylation
.teolytic
minal D
lved inhe presence of O-linked carbohydrates in the structure
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168 VOLCHKOVA, KLENK, AND VOLCHKOVf D-peptide has been confirmed by digestion with neur-
minidase and/or O-glycosidase (Fig. 5A). A reduction in
FIG. 3. EBOV sGP is cleaved at site R-V-R-R324. (A) Synthesis and
ecretion of sGP cleavage site mutant R324S (R-V-R-S). HeLa cells were
nfected with vTF7-3 and transfected with the plasmids pGEM-mGP7 (WT)
r pGEM-mGP7/R324S (R324S). At 18 h posttransfection, culture superna-
ants were separated by 10% SDS–PAGE under reducing conditions and
nalyzed for the presence of sGP-specific proteins by immunoblotting
sing goat anti-EBOV immunoglobulins. The consensus sequence of the
urin cleavage site as well as the sequences at the cleavage sites of
ild-type sGP and mutant R324S are shown on the top. (B) Effect of
ecanoylated peptidyl chloromethyl ketone (decRVKR-cmk) on cleavage of
BOV sGP. Vero-E6 cells infected with EBOV were washed 3 days postin-
ection with Dulbecco’s medium and incubated with or without decRVKR-
mk at a concentration of 25 mM. At 6 h posttreatment, culture superna-
ants were separated by 10% SDS–PAGE under reducing conditions and
nalyzed by immunoblotting using anti-EBOV immunoglobulins. (C) Cleav-
ge of sGP by recombinant furin in vitro. HeLa cells were infected with
SCGP7. At 4 h postinfection, cells were washed, starved in methionine-
ysteine-free medium for 1 h, and pulse-labeled for 20 min with 100 mCi/ml
35C]cysteine (Amersham, Germany). During starvation, labeling, and a
ubsequent chase of 240 min, cells were either treated with 60 mM of
ecRVKR-cmk or incubated without inhibitor. sGP-specific proteins were
mmunoprecipitated from culture medium using goat anti-EBOV immuno-
lobulins. Immunoprecipitated samples were incubated for 2 h at 37°C
ith or without purified recombinant furin. The samples were subse-
uently treated for 10 min at 37°C with SDS (2% end concentration) and
nalyzed on 15% polyacrylamide SDS gels under reducing conditions.ize of the D-peptide has been observed already after reuraminidase treatment alone, indicating the presence
f sialic acid. D-Peptide was converted to lower molec-
lar mass forms also after treatment with only O-glyco-
idase. Since O-glycosidase cannot remove O-linked
arbohydrates that contain sialic acid, this result indi-
ates that not all sugars of D-peptide are sialylated. The
olecular mass of D-peptide has been reduced to ap-
roximately 5 kDa after digestion with both neuramini-
ase and O-glycosidase and now coincided with the one
redicted from the amino acid sequence or with the size
f a synthetic peptide (data not shown). sGP digested
ith neuraminidase also showed a change in electro-
horetic mobility, indicating the presence of sialic acid.
ince digestion with O-glycosidase did not reveal any
ffect on electrophoretic mobility of sGP, it appears that
nly N-linked carbohydrates are present on this mole-
ule (Fig. 5B).
There are many viral transmembrane glycoproteins
ncluding EBOV surface glycoprotein GP (Volchkov et al.,
998a; Volchkov, 1999; Wool-Levis and Bates, 1999), that
re cleaved by furin or other cellular proprotein conver-
ases during their intracellular transport through the
olgi apparatus. Many of these proteins are directly or
ndirectly associated with fusion activity (Klenk and Gar-
en, 1994a,b; Stadler et al., 1997; White, 1990). However,
he range of proteins that are initially synthesized as
nactive precursors and are subsequently cleaved to
evelop full activity is significantly larger, covering many
eptide hormones, cell-adhesion factors, growth factors,
nd receptors (Molloy et al., 1999). To our knowledge, the
leavage of EBOV sGP is the first example where a
ecreted glycoprotein of viral origin is proteolytically pro-
essed by subtilisin-like endoproteases. High conserva-
ion of the sGP cleavage site in all EBOV subtypes
uggests that this cleavage plays an important role in
nfection.
MATERIALS AND METHODS
iruses and cell cultures
Strain Eckron of the Zaire subtype (provided by the
nstitut voor Tropische Geneeskunde, Antwerp, Belgium)
as propagated on Vero-E6 cells (ATCC CRL 1586) as
escribed previously (Volchkov et al., 1997). The recom-
inant vaccinia viruses vTF7-3, expressing T7 polymer-
se (provided by B. Moss, NIH, Bethesda, MD), and
SCGP7 expressing EBOV sGP (Volchkov et al., 1995)
ere propagated in Vero-E6 and/or CV-1 cells. CV-1,
eLa, and Vero-E6 cells were maintained in Dulbecco’s
edium containing 10% FCS (GIBCO, Germany).
ulse-chase experiments and immunoblot analysis
sGP expression in HeLa cells using the vaccinia/T7
olymerase expression system (transient expression) orecombinant vaccinia virus vSCGP7, immunoblot, and
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169PROTEOLYTIC PROCESSING OF EBOV sGPmmunoprecipitation analyses were carried out as de-
cribed previously (Volchkov et al., 1995; Volchkov et al.,
998a).
ligonucleotide-directed mutagenesis
The construction of the plasmid pGEM-mGP7 was de-
cribed previously (Volchkov et al., 1995). PCR mutagenesis
sing the QuikChange-mutagenesis kit (Stratagene, Ger-
any) according to the instructions of the manufacturer
FIG. 4. Intracellular processing of mutant sGP-His. HeLa cells were
longated by six carboxy-terminal histidine residues, or with pGEM-mGP
osttransfection, lysed cells and/or culture supernatants (B) were sep
resence of sGP-specific proteins by immunoblotting using either mou
ulse-chase analysis of sGP/His processing. HeLa cell monolayers we
osttransfection, cells were labeled with [35S]cysteine for 20 min and su
ysates were immunoprecipitated using mouse anti-His antibodies, s
luorography. Mock control represents HeLa cells infected with vaccin
ulture medium; C, lysed cells.as performed to generate sGP cleavage site mutant R324S wpGEM-mGP7/R324S), sGP/His mutant containing six histi-
ine residues at the carboxy-terminal end of the sGP open
eading frame (pGEM-mGP7/His), and a double mutant
ontaining a 6xHis tag and a mutated cleavage site (pGEM-
GP7/His-R324S). Clones with mutated sequences were
erified by sequence determination.
ndoproteolytic cleavage inhibition assay
For cleavage inhibition studies, Vero E6 cells infected
d with vTF7-3 and transfected with pGEM-mGP7/His expressing sGP
R324S expressing the sGP cleavage site mutant with a 6xHis tail. At 18 h
by 15% SDS–PAGE under reducing conditions and analyzed for the
i-His antibodies (A and B) or goat anti-EBOV immunoglobulins (B). (C)
ted with vTF7-3 followed by transfection with pGEM-mGP7/His. At 4 h
ently chased for various times as indicated. Labeled proteins from cell
ed on 15% SDS–PAGE under reducing conditions, and analyzed by
s VTF7-3 and transfected with plasmid expressing wild-type sGP. M,infecte
7/His-
arated
se ant
re infec
bsequ
eparat
ia viruith EBOV strain Eckron were washed 3 to 4 days postin-
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170 VOLCHKOVA, KLENK, AND VOLCHKOVection with Dulbecco’s medium and incubated without
r with the decanoylated peptidyl chloromethyl ketone
ecRVKR-cmk (kindly provided by W. Garten, Institute of
irology, Marburg, Germany) at concentrations of 25 or
0 mM for the next 6 h. For expression of recombinant
GP, HeLa cells infected with vSCGP7, were incubated
uring starvation, pulse, and chase periods either with-
ut or with the inhibitor at a concentration of 30 or 60 mM.
n vitro cleavage by furin
sGP expressed in the presence of inhibitor was im-
unoprecipitated as described earlier. Protein A–sepha-
ose with bound sGP was washed two times with 100
M Hepes buffer (pH 7.5), and finally treated with puri-
ied recombinant furin in the presence of 10 mM CaCl2 at
7°C for 2 h (Hallenberger et al., 1997). The samples
ere subsequently treated by SDS (2% end concentra-
ion) for 10 min at 37°C. Prior to loading onto 15% poly-
crylamide gels (SDS–PAGE), samples were boiled with
r without 5% b-mercaptoethanol. Precipitated proteins
ere visualized by fluorography or quantified with the
FIG. 5. Neuraminidase and O-glycosidase digestion of EBOV sGP.
eLa cells were infected with vTF7-3 followed by transfection either
ith pGEM-mGP7/His (A) or pGEM-mGP7 (B). At 22 h posttransfection,
ulture supernatants were collected and subjected to neuraminidase
nd/or O-glycosidase treatment. Digested samples were separated
ither by 15% (A) or 10% (B) SDS–PAGE under reducing conditions and
nalyzed by immunoblot using either mouse anti-His antibodies (A) or
nti-EBOV immunoglobulins (B).uji BAS 1000 Bio-Imaging Analyzer (Raytest, Germany). Mlycosidase treatment
Analyses were performed on recombinant sGP ex-
ressed from HeLa cells that were infected with vTF7-3
nd transfected with plasmid (pGEM-mGP7 or pGEM-
GP7/His). Culture supernatants were treated according
o the instruction of the suppliers of glycosidases. In the
ase of neuraminidase, reaction mixtures contained 50
M Na acetate, pH 5.5, and 1 mU of neuraminidase
Behring, Germany). After incubation at 37°C for 2 h,
amples were either subjected to analysis or were ad-
itionally treated with O-glycosidase. In the case of O-
lycosidase, reaction mixtures contained 50 mM Na
hosphate, pH 7.4, and 1 mU of O-glycosidase (Boeringer
annheim, Germany). Samples were treated at 37°C
vernight. Control samples were incubated under the
ame conditions but without the addition of glycosi-
ases. After digestions, samples were incubated in
uffer containing 2% SDS and 5% b-mercaptoethanol for
0 min at 37°C and subsequently separated on 10 or 15%
olyacrylamide gels, followed by immunoblot analysis
sing anti-His antibodies or anti EBOV immunoglobulins.
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